Latest Breaking News On - Department of immuntechnology at lund university - Page 12 : comparemela.com

Share this article LUND, Sweden, April 16, 2021 /PRNewswire/  Immunovia s bloodtest IMMray™ PanCan-d was mentioned in the seminar The latest in early detection for pancreatic cancer arranged by Pancreatic Cancer Action Network (pancan.org) on April 15, 2021. Dr. Rosalie Sears, professor in the department of molecular and medical genetics at Oregon Health and Science University, expressed her enthusiasm for Immunovias bloodtest and the test performance. She was especially impressed by the fact that a non-invasive bloodtest can be used to detect early stages I and II of pancreatic cancer which is crucial for improving treatment outcomes in pancreatic cancer care. Oregon Health and Science University is one out of 23 centers participating in Immunovia s study PanFAM-1, one of the largest prospective studies to date focusing on early diagnosis in high-risk individuals with Familial/Hereditary Pancreatic Cancer (FPC).

United statesPrnewswire immunoviaRosalie searsPatrik dahlenScience universityImmunovia dx laboratory in marlboroughPancreatic cancer action networkOregon healthDepartment of immuntechnology at lund universityHealth cancer centerHereditary pancreatic cancerLund universityCancer centerImmunovia dx laboratoryImmunovia abஒன்றுபட்டது மாநிலங்களில்